About US
Contact us
-
FujiFilm to Acquire Merck Biologic UnitsFujiFilm has announced plans to acquire the equity interests in two biological drug manufacturing units of Merck. The Japanese firm will acquire UK-based MSD Biologics and US-based Diosynth RTP, w2011/3/1
-
Bayer and Onyx Initiate Nexavar TrialBayer HealthCare and Onyx Pharmaceuticals have begun enrolling patients in a Phase III trial in order to evaluate Nexavar tablets in combination with oral chemotherapeutic capecitabine. The trial2011/2/28
-
NICE Advises Against Using Avastin as a First-Line Breast Cancer TreatmentBevacizumab, also known as Avastin, should not be used as a first-line treatment for people with metastatic breast cancer, the UK's National Institute for Health and Clinical Excellence (NICE) has sai2011/2/28
-
Avastin debate spills over until June FDA hearingBy Dr Ananya Mandal, MD The U.S. Food and Drug Administration have granted Roche a hearing in June to defend the cancer treatment Avastin. The hearing would examine the effectiveness of the drug in2011/2/28
-
CPhI Worldwide 2011We are delighted to announce the official opening of CPhI Worldwide 2011, taking place at Messe Frankfurt, Germany, from 25 – 27 October. With a substantial global visitor audience, a tailored con2011/2/25
-
ExcipientFest AmericasMay 10 - 11, 2011 - Renaissance Harborplace Hotel, Baltimore, MD Pharma Industry's BEST Event for Regulatory, Science and Sourcing Education ExcipientFest attracts Pharmaceutical Scientists fro2011/2/25
-
US Congressmen Vows to Fight for Drug Market CompetitionUS Congressman Henry Waxman has vowed to fight to promote competition within the pharmaceutical industry, adding that the US Food and Drug Administration's 32-month approval time for generic drugs is2011/2/25
-
Takeda submits NDA to FDA for fixed-dose combination of azilsartan medoxomil plus CLD to treat hypertensionTakeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc. U.S., submitted a New Drug Application (NDA) to the U.S. Food and Drug Adminis2011/2/25
-
Takeda and Lilly Cooperate with Actos InvestigationThe Attorney General of Texas, US, has requested documents relating to a recall of the diabetes drug Actos from pharmaceutical companies Takeda and Eli Lilly as part of an ongoing investigation into d2011/2/24
-
FDA Approves First Product to Treat Genetic Bleeding DisorderThe US Food and Drug Administration (FDA) has approved CSL Behring's Corifact, the first product intended to prevent bleeding in people with congenital Factor XIII deficiency, a rare genetic defect.2011/2/24